This is what analysts have to say about Stryker Corporation (NYSE:SYK) after last week.

October 2, 2018 - By Clifton Ray

Stryker Corporation (NYSE:SYK) LogoInvestors sentiment increased to 1.01 in 2018 Q2. Its up 0.25, from 0.76 in 2018Q1. It improved, as 35 investors sold Stryker Corporation shares while 352 reduced holdings. 110 funds opened positions while 281 raised stakes. 269.24 million shares or 1.56% less from 273.49 million shares in 2018Q1 were reported.
Nichols And Pratt Advisers Ltd Liability Partnership Ma stated it has 66,470 shares or 1% of all its holdings. Cibc Asset owns 45,206 shares. Dillon Associate accumulated 95,266 shares or 5.94% of the stock. Private Capital Advsr invested 2.19% of its portfolio in Stryker Corporation (NYSE:SYK). Hudock Cap Group Incorporated Lc has invested 0.01% in Stryker Corporation (NYSE:SYK). Scotia Cap owns 7,615 shares for 0.02% of their portfolio. Lau Assocs Ltd Llc holds 0.16% of its portfolio in Stryker Corporation (NYSE:SYK) for 1,400 shares. Boston Family Office Limited Liability Company has invested 1.01% of its portfolio in Stryker Corporation (NYSE:SYK). Dixon Hubard Feinour Brown Va owns 2.52% invested in Stryker Corporation (NYSE:SYK) for 51,263 shares. Riverbridge Prtn Ltd Liability has invested 0.01% of its portfolio in Stryker Corporation (NYSE:SYK). Oak Associate Oh has 0.07% invested in Stryker Corporation (NYSE:SYK). 8,003 were accumulated by Haverford Trust. Mitsubishi Ufj has invested 0.02% of its portfolio in Stryker Corporation (NYSE:SYK). Nomura Asset Management Limited reported 388,093 shares. Violich Cap Management invested in 5,600 shares.

Since April 16, 2018, it had 1 insider buy, and 4 insider sales for $7.70 million activity. 37,866 Stryker Corporation (NYSE:SYK) shares with value of $6.32 million were sold by Owen Katherine Ann. Boehnlein Glenn S also sold $120,000 worth of Stryker Corporation (NYSE:SYK) shares. Carpenter Lonny J also sold $832,103 worth of Stryker Corporation (NYSE:SYK) shares.

Stryker Corporation (NYSE:SYK) Ratings Coverage

Among 9 analysts covering Stryker (NYSE:SYK), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Stryker had 10 analyst reports since April 3, 2018 according to SRatingsIntel. Citigroup maintained Stryker Corporation (NYSE:SYK) rating on Wednesday, July 25. Citigroup has “Neutral” rating and $173 target. The firm earned “Buy” rating on Friday, April 27 by Canaccord Genuity. The firm has “Outperform” rating given on Wednesday, July 25 by Robert W. Baird. Cantor Fitzgerald maintained it with “Neutral” rating and $175 target in Wednesday, July 25 report. On Tuesday, May 1 the stock rating was maintained by Citigroup with “Neutral”. The firm has “Buy” rating by Stifel Nicolaus given on Friday, April 27. Below is a list of Stryker Corporation (NYSE:SYK) latest ratings and price target changes.

16/08/2018 Broker: BTIG Research Rating: Buy New Target: $187 Initiates Coverage On
25/07/2018 Broker: Robert W. Baird Old Rating: Outperform New Rating: Outperform Old Target: $187 New Target: $192 Maintain
25/07/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $171 New Target: $173 Maintain
25/07/2018 Broker: Cantor Fitzgerald Old Rating: Neutral New Rating: Neutral Old Target: $170 New Target: $175 Maintain
27/06/2018 Broker: Bernstein Rating: Market Perform New Target: $177 Initiates Coverage On
01/05/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $166 New Target: $171 Maintain
27/04/2018 Broker: Canaccord Genuity Rating: Buy New Target: $185.0000 Maintain
27/04/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $183 New Target: $187 Maintain
16/04/2018 Broker: Morgan Stanley Rating: Buy
03/04/2018 Broker: Evercore Rating: In-Line New Target: $165 Initiates Coverage On

The stock decreased 0.72% or $1.28 during the last trading session, reaching $177.37. About 264,498 shares traded. Stryker Corporation (NYSE:SYK) has risen 20.73% since October 2, 2017 and is uptrending. It has outperformed by 5.11% the S&P500.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company has market cap of $66.34 billion. It operates through three divisions: Orthopaedics; MedSurg; and Neurotechnology and Spine. It has a 62.63 P/E ratio. The Orthopaedics segment offers implants for use in hip and knee joint replacements, and trauma and extremities surgeries.

More important recent Stryker Corporation (NYSE:SYK) news were published by: Seekingalpha.com which released: “On Stryker’s Value” on September 13, 2018, also Streetinsider.com published article titled: “SEC Charges Stryker (SYK) A Second Time for FCPA Violations”, Seekingalpha.com published: “Stryker acquires HyperBranch Medical” on October 01, 2018. More interesting news about Stryker Corporation (NYSE:SYK) was released by: Streetinsider.com and their article: “Stryker (SYK) Acquires HyperBranch Medical Technology to $220 Million” with publication date: October 01, 2018.

Stryker Corporation (NYSE:SYK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>